Moderna Teases M&A Interest As Pandemic Expected To Wind Down

Biotech Anticipates Four Phase III Programs In Clinic in Q2

 
• By Alaric DeArment
  
Moderna and Pfizer covid vaccines
Moderna announced its first quarter 2022 earnings • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business